HDAC2 regulates cell proliferation, cell cycle progression and cell apoptosis in esophageal squamous cell carcinoma EC9706 cells.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Oncology Letters

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ol.2016.5436PMID 28123574PMCID PMC5244900
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histone deacetylase 2 regulates doxorubicin (Dox) sensitivity of colorectal cancer cells by targeting ABCB1 transcription

  2016cited by this paper
• HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population

  2015cited by this paper
• Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis.

  2014cited by this paper
• Target protein for Xklp2 (TPX2), a microtubule-related protein, contributes to malignant phenotype in bladder carcinoma

  2013cited by this paper
• Left Thoracoabdominal Approach in Surgical Treatment of Adenocarcinoma of the Esophagogastric Junction in the Northern Henan Province of China

  2011cited by this paper
• Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis

  2011cited by this paper
• Overexpression of Pim‐1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma

  2010cited by this paper
• Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression.

  2010cited by this paper
• Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma

  2010cited by this paper
• Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells.

  2010cited by this paper
• Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker

  2009cited by this paper
• Histone deacetylases: salesmen and customers in the post‐translational modification market

  2009cited by this paper
• HDAC2: a critical factor in health and disease.

  2009cited by this paper
• HDAC1 and HDAC2 Regulate Oligodendrocyte Differentiation By Disrupting β-Catenin-TCF Interaction

  2009cited by this paper
• HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA

  2009cited by this paper
• HDAC expression and clinical prognosis in human malignancies.

  2009cited by this paper
• Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients.

  2009cited by this paper
• Esophageal cancer: current and emerging therapy modalities

  2008cited by this paper
• Isoform-selective histone deacetylase inhibitors.

  2008cited by this paper
• Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer

  2008cited by this paper
• An activated Notch1 signaling pathway inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma cell line EC9706.

  2008cited by this paper
• Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity.

  2007cited by this paper
• Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells

  2006cited by this paper
• Histone Deacetylase Inhibitors Down-Regulate bcl-2 Expression and Induce Apoptosis in t(14;18) Lymphomas

  2005cited by this paper
• Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1

  2005cited by this paper
• Clinical trial of valproic acid and all‐trans retinoic acid in patients with poor‐risk acute myeloid leukemia

  2005cited by this paper
• Specific and Redundant Functions of Histone Deacetylases in Regulation of Cell Cycle and Apoptosis

  2004cited by this paper
• Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis.

  2004cited by this paper
• Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970–90

  2002cited by this paper
• Cancer burden in the year 2000. The global picture.

  2001cited by this paper
• Molecular biology of esophageal squamous cell carcinoma.

  2000cited by this paper

• Unfolding the role of HDAC2 in the epigenetic puzzle of cancer: A dive into molecular pathways for precision-driven multi-target therapy.

  2025cites this paper
• DAZL regulate germline, pluripotency, and proliferation related genes in chicken PGCs and cooperate with DDX4.

  2024cites this paper
• Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives

  2024cites this paper
• Deciphering the Mysterious Relationship between the Cross-Pathogenetic Mechanisms of Neurodegenerative and Oncological Diseases

  2023cites this paper
• A computational framework for the inference of protein complex remodeling from whole-proteome measurements

  2023cites this paper
• Ginsenoside Rh4 inhibits breast cancer growth through targeting histone deacetylase 2 to regulate immune microenvironment and apoptosis.

  2023cites this paper
• Chronic exposure to (2 R,6 R)-hydroxynorketamine induces developmental neurotoxicity in hESC-derived cerebral organoids.

  2023cites this paper
• Role of microRNA-146a in cancer development by regulating apoptosis.

  2023cites this paper
• Microglial histone deacetylase 2 is dispensable for functional and histological outcomes in a mouse model of traumatic brain injury

  2023cites this paper
• Promotion of microRNA-146a by histone deacetylase 4 silencing contributes to radiosensitization of esophageal carcinoma

  2022cites this paper
• Assessment of the anti-tumor activity of cyanidin-3-O-arabinoside from apple against APN, JAK, and EZH2 target proteins

  2022cites this paper
• Transcriptomic analysis reveal the responses of dendritic cells to VDBP

  2022cites this paper
• Deficiency of Parkinson’s Related Protein DJ-1 Alters Cdk5 Signalling and Induces Neuronal Death by Aberrant Cell Cycle Re-entry

  2022cites this paper
• Hyperphosphorylation of HDAC2 promotes drug resistance in a novel dual drug resistant mouse melanoma cell line model: an in vitro study.

  2021cites this paper
• HDAC2 enhances esophageal squamous cell carcinoma development through down-regulating microRNA-503-5p and promoting CXCL10

  2021cites this paper
• Histone deacetylase HDAC2 silencing prevents endometriosis by activating the HNF4A/ARID1A axis

  2021cites this paper
• Histone deacetylase 2: A potential therapeutic target for cancer and neurodegenerative disorders.

  2021cites this paper
• Epigenetics in Esophageal Cancer: From Mechanisms to Therapeutics

  2020cites this paper
• HDAC Overexpression in a NUT Midline Carcinoma of the Parotid Gland with Exceptional Survival: A Case Report

  2020cites this paper
• MicroRNA‐34a‐mediated death of acute myeloid leukemia stem cells through apoptosis induction and exosome shedding inhibition via histone deacetylase 2 targeting

  2020cites this paper
• CAY10683 and imatinib have synergistic effects in overcoming imatinib resistance via HDAC2 inhibition in chronic myeloid leukemia

  2020cites this paper
• Combined exposure of lead and cadmium leads to the aggravated neurotoxicity through regulating the expression of histone deacetylase 2.

  2020cites this paper
• Clinical significance of HDAC1, -2 and -3 expression levels in esophageal squamous cell carcinoma

  2020cites this paper
• miR-489-3p inhibits proliferation and migration of bladder cancer cells through downregulation of histone deacetylase 2

  2020cites this paper
• Upregulated histone deacetylase 2 gene correlates with the progression of oral squamous cell carcinoma

  2020influential citation
• HDAC2‐mediated proliferation of trophoblast cells requires the miR‐183/FOXA1/IL‐8 signaling pathway

  2020cites this paper
• Spatiotemporal dissection of the cell cycle with single-cell proteogenomics

  2019cites this paper
• AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma

  2019cites this paper
• Histone deacetylase inhibitors differentially regulate c-Myc expression in retinoblastoma cells

  2019cites this paper
• Prognostic value and prospective molecular mechanism of miR-100-5p in hepatocellular carcinoma: A comprehensive study based on 1,258 samples

  2019cites this paper
• MiR-34a affects dexmedetomidine-inhibited chronic inflammatory visceral pain by targeting to HDAC2

  2019cites this paper
• Histone deacetylases inhibitor MS‐275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway

  2019cites this paper
• Chidamide induces necroptosis via regulation of c‑FLIPL expression in Jurkat and HUT‑78 cells.

  2019cites this paper
• DDDT_A_211665 4321..4330

  2019cites this paper
• Regulatory Roles of Histone Deacetylases 1 and 2 in Pb-induced Neurotoxicity

  2018cites this paper
• RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.

  2018cites this paper
• Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases

  2018cites this paper
• HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease

  2018cites this paper
• Magnesium isoglycyrrhizinate promotes the activated hepatic stellate cells apoptosis via endoplasmic reticulum stress and ameliorates fibrogenesis in vitro and in vivo

  2017cites this paper